| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Department of Immunology, The Scripps Research Institute, La Jolla, California 92037
The olfactory marker protein (OMP) is a Mr 19,000 polypeptide originally considered a selective marker for differentiated olfactory receptor neurons. In an attempt to induce neoplastic proliferation in the olfactory cells, we made mice transgenic for the simian virus 40 large T-antigen gene linked to the OMP gene promoter. Four independent lines of transgenic mice were established. Despite a high expression of the transgene in the olfactory receptor neurons, no evidence of tumor growth was observed. Instead, starting from an age of 4 months, animals of all four lines presented with highly metastatic tumors originating in the adrenal medullas or sympathetic ganglia. The histological, ultrastructural, and immunohistochemical features of the tumors were identical to those of human infant neuroblastoma. Five independent neuroblastoma cell lines were established from tumors of different transgenic animals. All cell lines constitutively express the endogeneous OMP gene. The transgene product, simian virus 40 large T-antigen, associates with the product of the anti-oncogene p53 in these cell lines. This transgene system not only offers a biologically faithful model for investigations on the pathogenesis of neuroblastoma, the most common solid neoplasia of infancy, it also raises intriguing questions about the role of the OMP gene for the differentiation of the sympathetic neurons.
1 This work was funded by grants from the Swedish Cancer Society (1817), Swedish Medical Research Council (08879/09468), John and Augusta Persson foundation (JAP 1989/126, 1990/133, 1991/92, and 1992/106), GA&E Nilsson foundation, the Medical Faculty, Lund University (to B. S.), and The Academy of Finland (to L. C. A.).
2 To whom requests for reprints should be addressed, at Department of Medical Molecular Biology, The Wallenberg Laboratory, University of Lund, Box 7031, S-220 07 Lund, Sweden.
3 Current address: Baxter Healthcare Corp., 3015 S. Daimler St., Santa Ana, CA 92705.
4 Current address: Department of Pathology, University of Helsinki, Haartmaninkatu 3, FIN-00250 Helsinki, Finland.
Received 3/16/94. Accepted 7/29/94.
This article has been cited by other articles:
![]() |
M. Alenius and S. Bohm Differential function of RNCAM isoforms in precise target selection of olfactory sensory neurons Development, March 1, 2003; 130(5): 917 - 927. [Abstract] [Full Text] [PDF] |
||||
![]() |
T Sourisseau, C Desbois, L Debure, D. Bowtell, A. Cato, J Schneikert, E Moyse, and D Michel Alteration of the stability of Bag-1 protein in the control of olfactory neuronal apoptosis J. Cell Sci., January 4, 2001; 114(7): 1409 - 1416. [Abstract] [PDF] |
||||
![]() |
T. Flagstad, P. A. Andresen, J. I. Johnsen, S. K. Asomani, G.-E. Jorgensen, S. Vignarajan, A. Kjuul, P. Kogner, and T. Traavik A Possible Contributory Role of BK Virus Infection in Neuroblastoma Development Cancer Res., March 1, 1999; 59(5): 1160 - 1163. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |